Christopher C.T. Sng
Impact in
- Oncology top 5%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 11
- COVID-19 and healthcare impacts 10
- Inflammatory Biomarkers in Disease Prognosis 2
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Yien Ning Sophia Wong (4 shared papers)Sarah Benafif (3 shared papers)Rebecca R. Roylance (2 shared papers)Anjui Wu (2 shared papers)Neha Chopra (3 shared papers)Gehan Soosaipillai (3 shared papers)Myria Galazi (3 shared papers)Heather S. Shaw (2 shared papers)
- Journals
- Annals of Oncology (3 papers)The Lancet Oncology (3 papers)European Journal of Cancer (2 papers)Cancers (2 papers)World Journal of Urology (1 paper)
- Partner nations
- United KingdomSpainItaly
In The Last Decade
Christopher C.T. Sng
20 papers receiving 1.0k citations
Christopher C.T. Sng's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 659
- Infectious Diseases 376
- Neurology 96
- Health 30
- Obstetrics and Gynecology 23
Countries citing papers authored by Christopher C.T. Sng
This map shows the geographic impact of Christopher C.T. Sng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C.T. Sng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C.T. Sng more than expected).
Fields of papers citing papers by Christopher C.T. Sng
This network shows the impact of papers produced by Christopher C.T. Sng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C.T. Sng. The network helps show where Christopher C.T. Sng may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher C.T. Sng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 443 |
| 2 | 2020 | 150 | |
| 3 | 2021 | 92 | |
| 4 | 2022 | 66 | |
| 5 | 2020 | 53 | |
| 6 | 2022 | 44 | |
| 7 | 2021 | 42 | |
| 8 | 2021 | 28 | |
| 9 | 2022 | 28 | |
| 10 | 2020 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2018 | 11 | |
| 13 | 2020 | 4 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2020 | 1 | |
| 20 | 2024 | 1 |
About Christopher C.T. Sng
Christopher C.T. Sng is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Internal Medicine and Genetics, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (10 papers), COVID-19 Clinical Research Studies (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Infection Control and Ventilation (1 paper), Complement system in diseases (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Oncology (659 citations), Infectious Diseases (376 citations), Neurology (96 citations), Health (30 citations) and Obstetrics and Gynecology (23 citations). Christopher C.T. Sng has collaborated with scholars based in United Kingdom, Spain and Italy. Frequent co-authors include Yien Ning Sophia Wong, Sarah Benafif, Rebecca R. Roylance, Anjui Wu, Neha Chopra, Gehan Soosaipillai, Myria Galazi, Heather S. Shaw, Alvin J. X. Lee and Diego Ottaviani. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, European Journal of Cancer, Cancers and World Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.